Of note, the AUROC analysis indicates that no single lipid predicted case/control status better than 71% accuracy after adjusting for age, sex, PNPLA3 genotype, diabetes and metabolic syndrome. This evidence concerns the gene PNPLA3 and metabolic syndrome.